toposar- etoposide injection, solution, concentrate
teva parenteral medicines, inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - toposar (etoposide injection) is indicated in the management of the following neoplasms: toposar (etoposide injection) in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. toposar is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.
etoposide- etoposide injection, solution
fresenius kabi usa, llc - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - etoposide injection, usp is indicated in the management of the following neoplasms: etoposide injection, usp in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. adequate data on the use of etoposide capsules in the treatment of testicular cancer are not available. etoposide injection, usp and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. etoposide injection, usp is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.
toposar etoposide injection solution concentrate
teva parenteral medicines, inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml
etoposide injection
accord healthcare inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - etoposide injection usp is indicated in the management of the following neoplasms: etoposide injection usp in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection usp in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. etoposide injection usp is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.
etoposide capsule
mylan pharmaceuticals inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 50 mg - etoposide capsules are indicated in the management of the following neoplasms: etoposide capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. etoposide capsules are contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.
vepesid 50mg capsules
neon healthcare ltd - etoposide - oral capsule - 50mg
vepesid 100mg capsules
neon healthcare ltd - etoposide - oral capsule - 100mg
etopophos 100mg powder for solution for injection vials
neon healthcare ltd - etoposide phosphate - powder for solution for injection - 100mg
etoposide 100mg/5ml concentrate for solution for infusion vials
accord-uk ltd - etoposide - solution for infusion - 20mg/1ml
etoposide 100mg/5ml concentrate for solution for infusion vials
actavis uk ltd - etoposide - solution for infusion - 20mg/1ml